UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in DXCM — Dexcom Inc
CIK 861177
NEW YORK, NY
Position in DXCM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$758,487,343
+$146,427,622 QoQ
Shares Held
11,261,876
+15.6% QoQ
Ownership
2.98%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#9
of 951 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,740,663,804 across 61 Medical Devices names. DXCM ranks #3 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
12,835,753 | $1,164,716,222 | |
| 2 | SYK |
Stryker Corp
|
2,689,376 | $846,723,135 | |
| 3 | DXCM |
Dexcom Inc
This page
|
11,261,876 | $758,487,343 | |
| 4 | BSX |
Boston Scientific Corp
|
13,091,481 | $558,744,402 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,488,643 | $496,502,640 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
2,541,393 | $162,674,562 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
1,457,553 | $125,480,733 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
418,884 | $122,988,525 |
All Filings in DXCM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $758,487,343 | 11,261,876 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $612,059,721 | 9,746,174 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $530,897,406 | 7,999,057 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $503,499,504 | 7,482,531 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $797,011,288 | 9,130,614 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $691,335,513 | 10,123,525 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $559,810,541 | 7,198,284 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $425,596,527 | 6,348,397 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $711,630,015 | 6,276,504 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $603,214,616 | 4,349,060 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $543,743,511 | 4,381,848 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $381,754,950 | 4,091,693 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $527,248,122 | 4,102,779 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $476,660,857 | 4,102,779 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $436,978,433 | 3,858,870 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $337,189,641 | 4,186,611 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $303,693,796 | 4,074,786 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $526,974,086 | 1,030,051 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $536,788,371 | 999,699 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $607,115,762 | 1,110,185 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $491,207,136 | 1,150,368 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $324,997,451 | 904,303 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $155,577,431 | 420,798 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $124,594,040 | 302,244 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $119,080,571 | 293,736 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $84,343,706 | 313,231 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||